Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Ms. Hoki  Luk

Head of Investor Relations and Capital Markets & Corporate Development

Dr. W. Michael Korn M.D.

Chief Medical Officer

Ms. Ana J. Schrank

Chief Accounting Officer & Chief Financial Officer

Dr. David B. Sholehvar M.D.

Chief Operating Officer

Mr. Thomas R. Brida

General Counsel, Chief Compliance Officer & Secretary

Ms. Desarie  French

Chief Talent Officer

Mr. Robert  Guigley

Chief Commercial Officer

Ms. Shelly D. Guyer

Chief Sustainability Officer

Dr. Randal W. Scott Ph.D.

Co-Founder & Chairman of the Board

Mr. Kenneth D. Knight

President, Chief Executive Officer & Director

Nom de l'entreprise	Capitalisation boursière
Affimed N.V.	0M
Halozyme Therapeutics, Inc.	0M
Homology Medicines, Inc.	0M
Leafly Holdings, Inc.	0M
Walgreens Boots Alliance Inc	0M
Nektar Therapeutics	0M
Transgene SA	0M
Satudora Holdings Co.,Ltd.	0M
Camurus AB (publ)	0M
NEUCA S.A.	0M
Walgreens Boots Alliance, Inc.	0M

Invitae Corporation

Invitae Corporation Liste des concurrents

Principaux concurrents